Skip to main content
Clinical Trials/CTRI/2022/01/039385
CTRI/2022/01/039385
Not yet recruiting
未知

A study to assess the status of Ojas in the patients of Madhumeha; Type 2 Diabetes mellitus using Ojas Assessment Scale, Immunological Marker IgG and RBC Membrane Proteins.

All India Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Sponsor
All India Institute of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Trial Group\- Pre\-diagnosed subjects of Madhumeha; Type 2 DM (on oral hypoglycemics but not on Insulin therapy) of either gender, in age group 40\-60 years with minimum 10 years of diabetic history.
  • Control Group\- Non\-diabetic healthy subjects in the age group 40\-60 years with no history or
  • features of Madhumeha, any autoimmune and metabolic disorders.

Exclusion Criteria

  • Subjects suffering with Autoimmune disorders.
  • Subjects suffering with Tuberculosis, Cancer, Jaundice.
  • Subjects suffering with Rajyakshma, Shosha, Grahani, Pandu.
  • Subjects on medication for any infective disease.
  • Subjects not willing to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials